ACE and heart failure: ,7 Drugs targeting the RAAS intermediates, such as angiotensin-converting enzyme inhibitors, angiotensin receptor blockers (ARBs), and mineralocorticoid receptor antagonists (MRAs), can improve heart failure symptoms and outcomes and are widely employed in this population.8